Nuclear Her2 contributes to paclitaxel resistance in breast cancer cells.
Anticancer Drugs
; 32(7): 709-716, 2021 08 01.
Article
in En
| MEDLINE
| ID: mdl-33587352
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Paclitaxel
/
Receptor, ErbB-2
/
Drug Resistance, Neoplasm
Limits:
Female
/
Humans
Language:
En
Journal:
Anticancer Drugs
Journal subject:
ANTINEOPLASICOS
Year:
2021
Document type:
Article